Hims & Hers: Peptide Ruling A Positive, Operational Good Sense Makes 'Buy' Case (Upgrade)
We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-07-24T16:12:58.000Z","dateModified":"2026-07-24T16:15:18.000Z","description":"Hims & Hers stock is upgraded to \"Buy\" given its upside potential. This article was written byEdmund Ingham15.07K FollowersFollowEdmund Ingham is a biotech consultant.
- ▪We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools.
- ▪Invest.","telephone":"+1-347-509-6837","url":"https://seekingalpha.com"},"datePublished":"2026-07-24T16:12:58.000Z","dateModified":"2026-07-24T16:15:18.000Z","description":"Hims & Hers stock is upgraded to \"Buy\" given its upside potential
- ▪This article was written byEdmund Ingham15.07K FollowersFollowEdmund Ingham is a biotech consultant.
Seeking Alpha files mainly under finance. We currently carry 6,227 of its stories.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Stock Ideas","item":"https://seekingalpha.com/stock-ideas"},{"@type":"ListItem","position":3,"name":"Long Ideas","item":"https://seekingalpha.com/stock-ideas/long-ideas"},{"@type":"ListItem","position":4,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4925361-hims-and-hers-peptide-ruling-a-positive-operational-good-sense-makes-buy-case-upgrade"},"author":{"@type":"Person","name":"Edmund…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
